Clinical Trial Update: An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of sirukumab in adults with major depressive disorder; the trial has completed and results were posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Sirukumab (sirukumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Major | Phase 2 | Status: COMPLETED | Results posted: 2019-06-11